Department of Psychiatry, University of California San Diego, La Jolla, CA, USA; Research Service, VA San Diego Healthcare System, San Diego, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Neuropharmacology. 2020 May 1;167:107933. doi: 10.1016/j.neuropharm.2019.107933. Epub 2020 Jan 7.
Serotonergic hallucinogens such as lysergic acid diethylamide (LSD) induce head twitches in rodents via 5-HT receptor activation. The goal of the present investigation was to determine whether a correlation exists between the potency of hallucinogens in the mouse head-twitch response (HTR) paradigm and their reported potencies in other species, specifically rats and humans. Dose-response experiments were conducted with phenylalkylamine and tryptamine hallucinogens in C57BL/6J mice, enlarging the available pool of HTR potency data to 41 total compounds. For agents where human data are available (n = 36), a strong positive correlation (r = 0.9448) was found between HTR potencies in mice and reported hallucinogenic potencies in humans. HTR potencies were also found to be correlated with published drug discrimination ED values for substitution in rats trained with either LSD (r = 0.9484, n = 16) or 2,5-dimethoxy-4-methylamphetamine (r = 0.9564, n = 21). All three of these behavioral effects (HTR in mice, hallucinogen discriminative stimulus effects in rats, and psychedelic effects in humans) have been linked to 5-HT receptor activation. We present evidence that hallucinogens induce these three effects with remarkably consistent potencies. In addition to having high construct validity, the HTR assay also appears to show significant predictive validity, confirming its translational relevance for predicting subjective potency of hallucinogens in humans. These findings support the use of the HTR paradigm as a preclinical model of hallucinogen psychopharmacology and in structure-activity relationship studies of hallucinogens. Future investigations with a larger number of test agents will evaluate whether the HTR assay can be used to predict the hallucinogenic potency of 5-HT agonists in humans. "This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.
血清素能致幻剂,如麦角酸二乙酰胺(LSD),通过激活 5-HT 受体在啮齿动物中诱导头部抽搐。本研究的目的是确定在小鼠头部抽搐反应(HTR)模型中致幻剂的效力与在其他物种(特别是大鼠和人类)中的报道效力之间是否存在相关性。在 C57BL/6J 小鼠中进行了苯乙胺和色胺致幻剂的剂量反应实验,将 HTR 效力数据的可用池扩大到 41 种化合物。对于有人类数据的药物(n=36),在小鼠中的 HTR 效力与在人类中的报道致幻效力之间发现了很强的正相关(r=0.9448)。还发现 HTR 效力与在 LSD(r=0.9484,n=16)或 2,5-二甲氧基-4-甲基苯丙胺(r=0.9564,n=21)训练的大鼠中进行替代的药物辨别 ED 值相关。这三种行为效应(小鼠中的 HTR、大鼠中的致幻剂辨别刺激效应和人类中的迷幻效应)都与 5-HT 受体激活有关。我们提供的证据表明,致幻剂以非常一致的效力诱导这三种效应。除了具有高结构有效性外,HTR 测定法似乎还显示出显著的预测有效性,证实了其在预测人类致幻剂主观效力方面的转化相关性。这些发现支持将 HTR 范式用作致幻剂精神药理学的临床前模型,并用于致幻剂的结构-活性关系研究。未来将用更多的测试药物进行调查,以评估 HTR 测定法是否可用于预测人类 5-HT 激动剂的致幻效力。“本文是主题为“血清素研究:跨越尺度和边界”的特刊的一部分。